SCHEMBL753405

SCHEMBL753405

CC1(C)Oc2cc(NS(C)(=O)=O)cc(F)c2N(c2ccc(Cl)c(Cc3ccccc3C(=O)O)c2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 6/20 0.44
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
RCE1 Q9Y256 1/20 0.34
MAPK1 P28482 1/20 0.31
MCHR1 Q99705 1/20 0.31
EPHX2 P34913 1/20 0.31
NR1H4 Q96RI1 1/20 0.31
SLC16A3 O15427 1/20 0.30
SLC16A1 P53985 1/20 0.30
MCTS1 Q9ULC4 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
PTK2 Q05397 1/20 0.30
P2RX3 P56373 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL756042 0.87 NR3C2 (0.55) NR3C2ALDH1A1KDM4ERCE1EPHX2
SCHEMBL756053 0.85 NR3C2 (0.51) NR3C2EPHX2NR1H4
SCHEMBL753817 0.84 NR3C2 (0.43) NR3C2ALDH1A1EPHX2NR1H4SLC16A3
SCHEMBL755980 0.80 NR3C2 (0.56) NR3C2ALDH1A1MEN1KMT2A
SCHEMBL756283 0.79 NR3C2 (0.53) NR3C2
SCHEMBL754681 0.78 NR3C2 (0.53) NR3C2MCHR1MEN1KMT2A
SCHEMBL754215 0.78 NR3C2 (0.61) NR3C2ALDH1A1
SCHEMBL754664 0.77 NR3C2 (0.59) NR3C2EPHX2KCNH2
SCHEMBL755391 0.76 NR3C2 (0.72) NR3C2MEN1KMT2AKCNH2
SCHEMBL756893 0.74 NR3C2 (0.55) NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984345-B9 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS MITSUBISHI TANABE PHARMA CORP (JP) 2012-03-21 EP claimed
EP-1984345-B1 BENZOXAZINES AND RELATED NITROGEN-CONTAINING HETEROBICYCLIC COMPOUNDS USEFUL AS MINERALOCORTICOID RECEPTOR MODULATING AGENTS MITSUBISHI TANABE PHARMA CORP (JP) 2011-08-31 EP claimed